AB Akola Group reported a 4.4% year-over-year decline in revenue to €1.51 billion for the 12 months ended June 30, 2026, while net profit reached €43 million, a 29.5% decrease from the prior year. EBITDA totaled €96.4 million, down 12.9% from FY 2024/25 but exceeding the company’s revised target range of €80–100 million.
Food production remained the primary driver of profitability, contributing 61% of group EBITDA and 55% of total gross profit. Revenue in the segment rose 7.4% to €482 million, with gross profit expanding to €100 million from €85 million. Poultry operations were a key outlier, with gross profit increasing to €87 million from €69 million and margins widening to 24.7% from 21.2%. The food production segment’s operating profit contribution reached €58 million, accounting for 94% of the group’s total operating profit.
The Partners for Farmers segment, which represents 69% of total revenue at €1.047 billion, saw a 2.0% volume decline to 63,000 tons and gross profit fall to €80 million from €92 million. Gross profit margin in the segment compressed to 7.6% from 8.0%. Agricultural production reported a near-zero gross profit, with milk production volumes steady at 38,800 tons but prices down 30% year-over-year, while input and fertilizer costs rose by up to €100 per hectare.
Capital expenditures for FY 2025/26 totaled €44 million, moderating from €69 million in the prior year. Key investments included €13 million for poultry business upgrades, €11 million for a commercial biomethane facility, and €5 million for dairy farm modernization. The Lukšiai biogas plant became operational in July 2026. Management also highlighted evaluated projects such as a €20 million pet food production facility and a €70 million feed production expansion at Kauno Grūdai.
Net debt-to-EBITDA stood at 3.67x, adjusted for marketable inventories, remaining below the 4.0x ceiling. The equity ratio was 37%, with total assets reported at €1.068 billion. The company’s market capitalization was €278.4 million as of June 30, 2026, down from €300.9 million on August 14, 2026. The stock traded at $1.95, near its 52-week high of $1.955, with a 308% return since 2020, outperforming the OMXT Baltic Benchmark Value Index’s 211% gain over the same period.
